Butterfly Network (BFLY) Net Cash Flow Growth (3y) (2023 - 2026)
Butterfly Network (BFLY) Net Cash Flow Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.38 Bn | 176.08 Bn | 6.27 Bn | -32.51% |
| 2 | Stryker | 129.56 Bn | 126.68 Bn | 3.81 Bn | -87.87% |
| 3 | Medtronic | 109.00 Bn | 99.78 Bn | 6.41 Bn | 31.32% |
| 4 | Boston Scientific | 68.59 Bn | 67.13 Bn | 3.61 Bn | -11.49% |
| 5 | Edwards Lifesciences | 47.58 Bn | 43.90 Bn | 1.29 Bn | -87.88% |
| 6 | Dexcom | 28.65 Bn | 27.53 Bn | 750.30 Mn | 129.29% |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn | -65.12% |
| 8 | Smith & Nephew | 27.05 Bn | 26.48 Bn | - | - |
| 9 | Koninklijke Philips | 25.59 Bn | 22.46 Bn | 2.07 Bn | -48.90% |
| 10 | Butterfly Network | 1.73 Bn | 1.59 Bn | 18.29 Mn | -33.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33.82% |
| Dec 31, 2025 | 30.07% |
| Sep 30, 2025 | 68.05% |
| Jun 30, 2025 | 48.20% |
| Mar 31, 2025 | 46.46% |
| Dec 31, 2024 | -26.38% |
| Sep 30, 2024 | -27.29% |
| Jun 30, 2024 | -61.98% |
| Mar 31, 2024 | 19.21% |
| Dec 31, 2023 | -56.49% |
| Sep 30, 2023 | 7.99% |
| Jun 30, 2023 | -115.14% |
| Mar 31, 2023 | 52.98% |